Biocept Revenue and Competitors
Estimated Revenue & Valuation
- Biocept's estimated annual revenue is currently $15M per year.
- Biocept's estimated revenue per employee is $157,895
- Biocept's total funding is $43.2M.
Employee Data
- Biocept has 95 Employees.
- Biocept grew their employee count by -26% last year.
Biocept's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | President and CEO, Director | Reveal Email/Phone |
3 | Director and interim President and CEO | Reveal Email/Phone |
4 | VP, Operations | Reveal Email/Phone |
5 | VP Laboratory Operations | Reveal Email/Phone |
6 | SVP, Corporate Development | Reveal Email/Phone |
7 | VP Human Resources | Reveal Email/Phone |
8 | Senior Director, Head Managed Care | Reveal Email/Phone |
9 | Sr. Director, Translational Research and CLIA Development | Reveal Email/Phone |
10 | Director Managed Care (Payer Relations, Health Economics & Outcomes Research) | Reveal Email/Phone |
Biocept Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Biocept?
Biocept is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. The Company uses its proprietary liquid biopsy technology to provide physicians with information for treating and monitoring patients diagnosed with cancer. The Company\'s patented Target Selector™ liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and in plasma (ctDNA). With thousands of tests performed, the platform has demonstrated the ability to identify cancer mutations and alterations to inform physicians about a patient\'s disease and therapeutic options.
keywords:Biotechnology, Healthcare
$43.2M
Total Funding
95
Number of Employees
$15M
Revenue (est)
-26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Biocept News
Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for...
Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for...
Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for...
Biocept Reports Third Quarter 2021 Financial Results • Revenues for the third quarter of $17.5 million, up 165% over prior-year quarter, driven by increased RT-PCR COVID-19 testing, resulting in profitability; cash balance of $27.7 million at quarter-end • Robust CNSide™ sequential-quarter v ...
Biocept Reports Second Quarter 2021 Financial Results • Second quarter revenues of $12.0 million driven by RT-PCR COVID-19 testing • Continued sequential-quarter CNSide™ volume growth with customer base expanding to more than 30 leading U.S. academic institutions, including multiple repeat u ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $20M | 95 | 7% | N/A |
#2 | $13.8M | 95 | -26% | N/A |
#3 | $16.5M | 95 | 22% | N/A |
#4 | $16.5M | 95 | 19% | N/A |
#5 | $13.4M | 96 | -5% | $18.2M |